The Scientist

» US Supreme Court

Most Recent

image: Myriad, Post Mortem

Myriad, Post Mortem

By | June 1, 2016

David Schwartz of the Illinois Institute of Technology-Chicago, Kent College of Law, discusses the impact of the US Supreme Court unanimously striking down Myriad Genetics' patent of human BRCA genes and tests to detect mutations in them.

0 Comments

image: Governing Science

Governing Science

By | December 31, 2013

How the US government impacted life science research in 2013

1 Comment

image: Criminal Hype

Criminal Hype

By | September 25, 2013

Overstating the benefits of a drug lands a former biotech executive in home detention.

0 Comments

image: Speaking of Science

Speaking of Science

By | August 1, 2013

August 2013's selection of notable quotes

0 Comments

image: Another Lawsuit over Genetic Tests

Another Lawsuit over Genetic Tests

By | July 11, 2013

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing two competitors for patent infringement.

0 Comments

image: Speaking of Science

Speaking of Science

By | July 1, 2013

July 2013's selection of notable quotes

3 Comments

image: Gene Patents Decision: Everybody Wins

Gene Patents Decision: Everybody Wins

By | June 18, 2013

Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.

4 Comments

image: Opinion: On Patenting Genes

Opinion: On Patenting Genes

By | June 18, 2013

The scientific community and the impact of the Myriad Genetics Supreme Court decision

1 Comment

image: Week in Review, June 10–14

Week in Review, June 10–14

By | June 14, 2013

Supreme Court says no patenting (natural) genes; brain-computer interfaces mimic motor learning in brain; regenerating finger tips; gene therapy goes deeper; NIH needs more diversity; cross-border collaboration

0 Comments

image: Supreme Court Nixes Patenting Human Genes

Supreme Court Nixes Patenting Human Genes

By | June 13, 2013

The Justices have decided that isolated sequences of human DNA are not eligible for patent protection, but rules that artificial sequences can be patented.  

4 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech